52 Week Range
As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Oxford Immunotec Global Signs Agreement With Riken Genesis Co
Biolidics Enters Definitive Agreement With Sysmex Corp For Cancer Diagnostics Tests
Biolidics Executes Non-Binding Term Sheet With Sysmex Corp
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Scientific & Technical Instr.
Kokusai Kenko Kaihatsu Center Bldg.
1-5-1, Wakinohama Kaigandori, Chuo-ku
Chairman of the Board, President, Chief Executive Officer, Representative Director
Chief Financial Officer, Senior Managing Executive Officer, Director
Senior Managing Executive Officer, Chief Operating Officer of LS Business Unit, Chief Technology Officer, Director
Senior Managing Executive Officer, Chief Operating Officer of VD Business Unit, Director
Managing Executive Officer, Director
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.